Cargando…
Licensed Bacille Calmette-Guérin (BCG) formulations differ markedly in bacterial viability, RNA content and innate immune activation
BACKGROUND: Bacille Calmette-Guérin (BCG), the live attenuated tuberculosis vaccine, is manufactured under different conditions across the globe generating formulations that may differ in clinical efficacy. Innate immune recognition of live BCG contributes to immunogenicity suggesting that differenc...
Autores principales: | Angelidou, Asimenia, Conti, Maria-Giulia, Diray-Arce, Joann, Benn, Christine S., Shann, Frank, Netea, Mihai G., Liu, Mark, Potluri, Lakshmi Prasad, Sanchez-Schmitz, Guzman, Husson, Robert, Ozonoff, Al, Kampmann, Beate, van Haren, Simon Daniël, Levy, Ofer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556328/ https://www.ncbi.nlm.nih.gov/pubmed/32005538 http://dx.doi.org/10.1016/j.vaccine.2019.11.060 |
Ejemplares similares
-
Bacille Calmette–Guérin vaccine reprograms human neonatal lipid metabolism in vivo and in vitro
por: Diray-Arce, Joann, et al.
Publicado: (2022) -
Adjuvant Effect of Bacille Calmette–Guérin on Hepatitis B Vaccine Immunogenicity in the Preterm and Term Newborn
por: Scheid, Annette, et al.
Publicado: (2018) -
Human Newborn Monocytes Demonstrate Distinct BCG-Induced Primary and Trained Innate Cytokine Production and Metabolic Activation In Vitro
por: Angelidou, Asimenia, et al.
Publicado: (2021) -
Tuberculous Orchitis Following Intravesical Bacille Calmette-Guérin (BCG) Therapy
por: Klebanov, Nikolai, et al.
Publicado: (2018) -
Tuberculous Spondylitis after Intrarenal Bacille Calmette-Guerin (BCG) Therapy
por: Kajihara, Yusaku, et al.
Publicado: (2019)